US Stock MarketDetailed Quotes
ARTL Artelo Biosciences
- 1.1000
- -0.0202-1.80%
Close Oct 1 16:00 ET
3.55MMarket Cap-328P/E (TTM)
1.1584High1.0900Low3.68KVolume1.0900Open1.1202Pre Close4.21KTurnover0.12%Turnover RatioLossP/E (Static)3.23MShares1.780052wk High0.49P/B3.52MFloat Cap1.000052wk Low--Dividend TTM3.20MShs Float75.0000Historical High--Div YieldTTM6.11%Amplitude1.0000Historical Low1.1440Avg Price1Lot Size
Artelo Biosciences Stock Forum
Sign in to post a comment
$Artelo Biosciences (ARTL.US)$ SS’s are out in full force this morning!
1
$Artelo Biosciences (ARTL.US)$ Benzinga· 3 mins ago
Artelo Biosciences Receives FDA Clearance Of Its IND Application For ART26.12
Artelo Biosciences Receives FDA Clearance Of Its IND Application For ART26.12
$Artelo Biosciences (ARTL.US)$
Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor
Artelo Biosciences (Nasdaq: ARTL) has received FDA clearance for its Investigational New Drug (IND) application for ART26.12, a selective Fatty Acid Binding Protein 5 (FABP5) inhibitor. This clearance allows Artelo to initiate a Phase 1 single ascending dose study for chemotherapy-induced peripheral neuropathy (CIPN), a condition with...
Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor
Artelo Biosciences (Nasdaq: ARTL) has received FDA clearance for its Investigational New Drug (IND) application for ART26.12, a selective Fatty Acid Binding Protein 5 (FABP5) inhibitor. This clearance allows Artelo to initiate a Phase 1 single ascending dose study for chemotherapy-induced peripheral neuropathy (CIPN), a condition with...
1
$Artelo Biosciences (ARTL.US)$
Artelo Biosciences presented comparative preclinical data on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium. Findings revealed ART12.11, a novel cannabidiol: tetramethylpyrazine cocrystal, has a unique pharmacokinetic profile, potentially superior to existing...
Artelo Biosciences presented comparative preclinical data on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium. Findings revealed ART12.11, a novel cannabidiol: tetramethylpyrazine cocrystal, has a unique pharmacokinetic profile, potentially superior to existing...
$Artelo Biosciences (ARTL.US)$
Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society
Artelo Biosciences (Nasdaq: ARTL), a clinical-stage pharmaceutical company, presented new preclinical data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society. The conference took place from June 4-6, 2024, in Nottingham, UK. ART26.12, a Fatty Acid Binding Protein 5 (FABP5) inhibitor, showed efficacy in reducing b...
Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society
Artelo Biosciences (Nasdaq: ARTL), a clinical-stage pharmaceutical company, presented new preclinical data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society. The conference took place from June 4-6, 2024, in Nottingham, UK. ART26.12, a Fatty Acid Binding Protein 5 (FABP5) inhibitor, showed efficacy in reducing b...
1
$Artelo Biosciences (ARTL.US)$
NEWS
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
NEWS
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
Top after hours mover.
2.7 million float runner trading cash levels
$5 cash levels but trading 1.80 range.
Conference tomorrow at 12 pm EST.
$Artelo Biosciences (ARTL.US)$
Called $SciSparc (SPRC.US)$ $SuperCom (SPCB.US)$
$Novo Integrated Sciences (NVOS.US)$
2.7 million float runner trading cash levels
$5 cash levels but trading 1.80 range.
Conference tomorrow at 12 pm EST.
$Artelo Biosciences (ARTL.US)$
Called $SciSparc (SPRC.US)$ $SuperCom (SPCB.US)$
$Novo Integrated Sciences (NVOS.US)$
1
$Artelo Biosciences (ARTL.US)$ Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12!
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Daight : this is what happens when you have a short stick and can't stand anything long.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")